51
|
Sun W, Ji W, Hu Q, Yu J, Wang C, Qian C, Hochu G, Gu Z. Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine. Biomaterials 2016; 96:1-10. [PMID: 27131597 DOI: 10.1016/j.biomaterials.2016.04.011] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2016] [Revised: 03/29/2016] [Accepted: 04/13/2016] [Indexed: 01/24/2023]
Abstract
Direct delivery of cytokines using nanocarriers holds great promise for cancer therapy. However, the nanometric scale of the vehicles made them susceptible to size-dependent endocytosis, reducing the plasma membrane-associated apoptosis signaling. Herein, we report a tumor microenvironment-responsive and transformable nanocarrier for cell membrane targeted delivery of cytokine. This formulation is comprised of a phospholipase A2 (PLA2) degradable liposome as a shell, and complementary DNA nanostructures (designated as nanoclews) decorated with cytokines as the cores. Utilizing the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a model cytokine, we demonstrate that the TRAIL loaded DNA nanoclews are capable of transforming into nanofibers after PLA2 activation. The nanofibers with micro-scaled lengths efficiently present the loaded TRAIL to death receptors on the cancer cell membrane and amplified the apoptotic signaling with reduced TRAIL internalization.
Collapse
Affiliation(s)
- Wujin Sun
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Wenyan Ji
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Quanyin Hu
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Jicheng Yu
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Chao Wang
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Chenggen Qian
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Gabrielle Hochu
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA
| | - Zhen Gu
- Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
| |
Collapse
|
52
|
Boukari K, Caoduro C, Kacem R, Skandrani N, Borg C, Boulahdour H, Gharbi T, Delage-Mourroux R, Hervouet E, Pudlo M, Picaud F. Nanovectorization of DNA Through Cells Using Protamine Complexation. J Membr Biol 2016; 249:493-501. [DOI: 10.1007/s00232-016-9890-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2015] [Accepted: 03/16/2016] [Indexed: 12/22/2022]
|
53
|
Zakaria A, Picaud F, Guillaume YC, Gharbi T, Micheau O, Herlem G. Enhanced DR5 binding capacity of nanovectorized TRAIL compared to its cytotoxic version by affinity chromatography and molecular docking studies. J Mol Recognit 2016; 29:406-14. [DOI: 10.1002/jmr.2539] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2015] [Revised: 02/01/2016] [Accepted: 02/02/2016] [Indexed: 12/30/2022]
Affiliation(s)
- Albatoul Zakaria
- NanoMedicine, Imagery and Therapeutics Lab EA 4662; University of Franche-Comte, CHU Jean Minjoz; 25030 Besançon cedex France
| | - Fabien Picaud
- NanoMedicine, Imagery and Therapeutics Lab EA 4662; University of Franche-Comte, CHU Jean Minjoz; 25030 Besançon cedex France
| | - Yves Claude Guillaume
- NanoMedicine, Imagery and Therapeutics Lab EA 4662; University of Franche-Comte, CHU Jean Minjoz; 25030 Besançon cedex France
| | - Tijani Gharbi
- NanoMedicine, Imagery and Therapeutics Lab EA 4662; University of Franche-Comte, CHU Jean Minjoz; 25030 Besançon cedex France
| | - Olivier Micheau
- INSERM, UMR866, Faculty of Medicine and Pharmacy; Burgundy University; Dijon F-21079 France
| | | |
Collapse
|
54
|
Sajid MI, Jamshaid U, Jamshaid T, Zafar N, Fessi H, Elaissari A. Carbon nanotubes from synthesis to in vivo biomedical applications. Int J Pharm 2016; 501:278-99. [DOI: 10.1016/j.ijpharm.2016.01.064] [Citation(s) in RCA: 106] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2015] [Revised: 01/11/2016] [Accepted: 01/25/2016] [Indexed: 10/22/2022]
|
55
|
Zhang J, Zheng M, Xie Z. Co-assembled hybrids of proteins and carbon dots for intracellular protein delivery. J Mater Chem B 2016; 4:5659-5663. [DOI: 10.1039/c6tb01622g] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Co-assembled hybrids of carbon dots and proteins protect proteins against enzymatic hydrolysis and deliver them into HeLa cells.
Collapse
Affiliation(s)
- Jianxu Zhang
- State Key Laboratory of Polymer Physics and Chemistry
- Changchun Institute of Applied Chemistry
- Chinese Academy of Sciences
- Changchun
- P. R. China
| | - Min Zheng
- School of Chemistry and life Science
- Advanced Institute of Materials Science
- Changchun University of Technology
- Changchun
- P. R. China
| | - Zhigang Xie
- State Key Laboratory of Polymer Physics and Chemistry
- Changchun Institute of Applied Chemistry
- Chinese Academy of Sciences
- Changchun
- P. R. China
| |
Collapse
|
56
|
El Khalifi M, Bentin J, Duverger E, Gharbi T, Boulahdour H, Picaud F. Encapsulation capacity and natural payload delivery of an anticancer drug from boron nitride nanotube. Phys Chem Chem Phys 2016; 18:24994-25001. [DOI: 10.1039/c6cp01387b] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Payload delivery of anticancer cisplatin molecules assisted by the cell membrane lipid.
Collapse
Affiliation(s)
- M. El Khalifi
- Laboratoire de Nanomédecine
- Imagerie et Thérapeutique
- Université Bourgogne-Franche-Comté (UFR Sciences et Techniques)
- EA 4662
- 25030 Besançon
| | - J. Bentin
- Laboratoire de Nanomédecine
- Imagerie et Thérapeutique
- Université Bourgogne-Franche-Comté (UFR Sciences et Techniques)
- EA 4662
- 25030 Besançon
| | - E. Duverger
- Institut FEMTO-ST
- 32 Avenue de l'Observatoire
- 25044 Besançon
- France
| | - T. Gharbi
- Laboratoire de Nanomédecine
- Imagerie et Thérapeutique
- Université Bourgogne-Franche-Comté (UFR Sciences et Techniques)
- EA 4662
- 25030 Besançon
| | - H. Boulahdour
- Laboratoire de Nanomédecine
- Imagerie et Thérapeutique
- Université Bourgogne-Franche-Comté (UFR Sciences et Techniques)
- EA 4662
- 25030 Besançon
| | - F. Picaud
- Laboratoire de Nanomédecine
- Imagerie et Thérapeutique
- Université Bourgogne-Franche-Comté (UFR Sciences et Techniques)
- EA 4662
- 25030 Besançon
| |
Collapse
|
57
|
Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). Mar Drugs 2015; 13:6884-909. [PMID: 26580630 PMCID: PMC4663558 DOI: 10.3390/md13116884] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2015] [Revised: 11/02/2015] [Accepted: 11/09/2015] [Indexed: 12/14/2022] Open
Abstract
Marine biomass diversity is a tremendous source of potential anticancer compounds. Several natural marine products have been described to restore tumor cell sensitivity to TNF-related apoptosis inducing ligand (TRAIL)-induced cell death. TRAIL is involved during tumor immune surveillance. Its selectivity for cancer cells has attracted much attention in oncology. This review aims at discussing the main mechanisms by which TRAIL signaling is regulated and presenting how marine bioactive compounds have been found, so far, to overcome TRAIL resistance in tumor cells.
Collapse
|
58
|
Zhang X, Gong X. DFT, QTAIM, and NBO investigations of the ability of the Fe or Ni doped CNT to absorb and sense CO and NO. J Mol Model 2015; 21:225. [PMID: 26254940 DOI: 10.1007/s00894-015-2778-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2015] [Accepted: 07/28/2015] [Indexed: 12/30/2022]
Abstract
The structures and intramolecular interactions of complexes (FeCNT-CO, FeCNT-NO, NiCNT-CO, and NiCNT-NO) formed by the Fe or Ni doped single-wall carbon nanotube (FeCNT or NiCNT) and gas CO or NO were studied using density functional theory, quantum theory of atom in molecule (QTAIM), and natural bond orbital methods. The adsorption processes of CO and NO on surfaces of FeCNT and NiCNT are chemisorption, energetically favored, exothermic, and spontaneous. High temperature is not good for adsorption. Introducing NO more obviously elongates the distances between Fe/Ni and C atoms and decreases ∠CFe(Ni)C than adding CO. QTAIM analysis shows that the covalent bonding interactions of FeCNT-NO (NiCNT-NO) are stronger than that of FeCNT-CO (NiCNT-CO). NO plays a role of electron acceptor while CO is electron donator in complexes. Electrostatic interaction of FeCNT-NO (NiCNT-NO) is stronger than that of FeCNT-CO (NiCNT-CO). The stronger intramolecular interactions of FeCNT-NO and NiCNT-NO reveal that FeCNT and NiCNT are more effective to adsorb and sense NO than CO. CO and NO considerably change the electronic properties of FeCNT and NiCNT, which is useful for designing sensors for CO and NO.
Collapse
Affiliation(s)
- Xueli Zhang
- Department of Chemistry, Nanjing University of Science and Technology, Nanjing, 210094, People's Republic of China
| | | |
Collapse
|